CS257399B1 - B-Formainido2 benzotiaw) líntión - Google Patents

B-Formainido2 benzotiaw) líntión Download PDF

Info

Publication number
CS257399B1
CS257399B1 CS87927A CS92787A CS257399B1 CS 257399 B1 CS257399 B1 CS 257399B1 CS 87927 A CS87927 A CS 87927A CS 92787 A CS92787 A CS 92787A CS 257399 B1 CS257399 B1 CS 257399B1
Authority
CS
Czechoslovakia
Prior art keywords
compound
benzothiazolinothione
antimycobacterial
formamido
amino
Prior art date
Application number
CS87927A
Other languages
Czech (cs)
Slovak (sk)
Other versions
CS92787A1 (en
Inventor
Eva Sidoova
Zelmira Odlerova
Original Assignee
Eva Sidoova
Zelmira Odlerova
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eva Sidoova, Zelmira Odlerova filed Critical Eva Sidoova
Priority to CS87927A priority Critical patent/CS257399B1/en
Publication of CS92787A1 publication Critical patent/CS92787A1/en
Publication of CS257399B1 publication Critical patent/CS257399B1/en

Links

Landscapes

  • Plural Heterocyclic Compounds (AREA)

Abstract

Riešenie sa týká doteraz neznámého 6- -formamido-2-benzotiazolíntiónu vzorea HCG"nh lf C= s a sposobu jeho přípravy. Reakcia sa uskutočňuje formyláciou 6- -amíno-2-benzotiazolíntiónu 85 %-nou kyselinou mravčou pri teplote varu. Nová zlúčenina je antimykobakteriálne účinná proti tuberkulóznym mykobaktériám, najma proti atypickým kmeňom M. avium, M. fortuitum a M. kansasii; možno ju používat ako účinnú zložku antimykobakteriálnych prípravkov, alebo ako medziprodukt pre ďalšie syntézy.The solution concerns a previously unknown 6- -formamido-2-benzothiazolinethione of the formula HCG"nh lf C= s and a method of its preparation. The reaction is carried out by formylation of 6- -amino-2-benzothiazolinethione with 85% formic acid at boiling temperature. The new compound is antimycobacterially effective against tuberculous mycobacteria, especially against atypical strains of M. avium, M. fortuitum and M. kansasii; it can be used as an active ingredient of antimycobacterial preparations, or as an intermediate for further syntheses.

Description

Riešenie sa týká doteraz neznámého 6-formamido-2-benzotiazolíntiónu vzorca HCO"nh lj c= a sposobu jeho přípravy.The solution relates to the hitherto unknown 6-formamido-2-benzothiazolinothione of the formula HCO "nh 1jc = and the process for its preparation.

Reakcia sa uskutočňuje formyláciou 6- -amíno-2-henzotiazolíntiónu 85 %-nou kyselinou mravčou pri teplote varu. Nová zlúčenina je antimykohakteriálne účinná proti tuberkulóznym mykobaktériám, najma proti atypickým kmeňom M. avium, M. fortuitum a M. kansasii; možno ju používat ako účinnú zložku antimykobakteriálnych prípravkov, alebo ako medziprodukt pre dalšie syntézy. 257399 257399The reaction is performed by formylation of 6-amino-2-benzothiazolinothione with 85% formic acid at boiling point. The new compound is antimycohacterially effective against tuberculous mycobacteria, especially against atypical M. avium strains, M. fortuitum and M. kansasii; it can be used as an active ingredient of antimycobacterial preparations, or as an intermediate for further syntheses. 257399 257399

Predmetom vynálezu je 6-formamido-2-benzotiazolíntión. 2-Benzotiazolíntión je antimikrobiláne účinná zlúčenina. Ako fungicid je účinnou zložkou zavedeného preparátu Dermacid, okrem toho je účinný aj antimykobakteriálne.The present invention provides 6-formamido-2-benzothiazolinothione. 2-Benzothiazolinothione is an antimicrobial active compound. As a fungicide, it is an effective component of the established Dermacid formulation, and is also effective as an antimycobacterial.

Teraz bolo zistené, že do teraz neznáma zlúčenina vzorca je účinná proti typickým tuberkulóznym mykobaktériám Mycobacterium (M.) tuberculosis H37RV, aj proti atypickým tuherkulóznym mykobaktériám M. kansasii. M. avium a M. fortuitum. Súčasne bol zistený sposob přípravy uvedenej zlúčeniny na báze 6-amíno-2-benzotiazolíntiónu. Reakcia sa uskutočňuje acyláciou 6-amíno-2-benzotiazolíntiónu 85 %-nou kyselinou mravčou v molárnom pomere 1: : 4 až 1 : 12 pri teplote 70 až 101 °C po dobu 1 až 30 minút.It has now been found that the now unknown compound of the formula is effective against typical tuberculous mycobacteria Mycobacterium (M.) tuberculosis H37RV, as well as against atypical M. kansasii mycobacterial mycobacteria. M. avium and M. fortuitum. At the same time, a method for preparing said 6-amino-2-benzothiazolinothione-based compound was found. The reaction is carried out by acylating 6-amino-2-benzothiazolinothione with 85% formic acid in a 1: 4 to 1: 12 molar ratio at 70-101 ° C for 1 to 30 minutes.

Látka MIC tbc.MIC fabric tbc.

H37RVH37RV

Nasledujúce příklady bližšie osvetfujú, ale nijako neobmedzujú přípravu a vlastnosti zlúčeniny podta vynálezu. Příklad 1 Příprava 6-formamido-2-benzotiazolíntiónu 6-Amíno-2-benzotiazolyntión (5,45 g, 0,03 molu) a 85 %-ná kyselina mravčia (7,5 cm3, 9 g, 0,166 molu) boli spolu zahriate do varu. Po dvoch minútach varu sa zmes odstavila na 30 minút, potom sa vyliala do studenej vody (300 cm3). Získal sa čistý 6-formamido-2-benzotiazolíntión o t. t. 257 až 259,5 °C za rozkladu, ktorý okrem dokladného premývania vodou do neutrálnej reakcie nevyžadoval ďalšie čistenie. Výťažok činil 5,7 g (89,5 %).The following examples illustrate, but do not limit, the preparation and properties of the compound of the invention. Example 1 Preparation of 6-formamido-2-benzothiazolinothione 6-Amino-2-benzothiazolynthion (5.45 g, 0.03 mol) and 85% formic acid (7.5 cm 3, 9 g, 0.166 mol) were heated together to boil. After two minutes of boiling, the mixture was left to stand for 30 minutes, then poured into cold water (300 cm 3). Pure 6-formamido-2-benzothiazolinothione was obtained, m.p. 257-259.5 ° C with decomposition, which did not require further purification in addition to a neutral wash with water. The yield was 5.7 g (89.5%).

Pre C8H6N2OS2 (212,29) vypočítané: 45,26 % C, 3,80 % H, 13,20 % N, 30,21 O/o S, zistené: 45,56 % C, 3,67 % H, 13,08 % N, 30,32 % S. Příklad 2For C8H6N2OS2 (212.29) calculated: 45.26% C, 3.80% H, 13.20% N, 30.21% O / S, found: 45.56% C, 3.67% H, 13 N, 30.32%. Example 2

Antimykobakteriálna účinnost zlúčeniny podl'a vynálezu v porovnaní s účinnosťou známých antituberkulotík oproti Mycobacterium (^g . cm-3) kansasii avium fortuitum PKG 8 16/18 č. 1 021The antimycobacterial activity of the compound of the invention compared to that of known antituberculotics versus Mycobacterium (^ g-cm-3) kansasii avium fortuitum PKG 8 16/18 No. 1,021

Zlúčenina podta vynálezu 25 25 25 50 Izoniazid (INH) 1 5 50 25 Etionamid (ETA) 5 25 25 50 MIC — minimálna inhibičná koncentrácia v pg . cm-3Compound of the Invention 25 25 25 50 Isoniazid (INH) 1 5 50 25 Etionamide (ETA) 5 25 25 50 MIC - Minimum inhibitory concentration in pg. cm-3

Antimykobakteriálna účinnost proti tuberkulóznym mykobaktériám bola sledovaná v tekutej Šulovej pode zrieďovacím testom. Ako rozpúšťadlo bol použitý dimetylsulfoxid. Výsledná koncentrácia látok v pode bola 0,5, 1, 5, 10, 25, 50 a 100 :ug . cm'3. Významný je fakt, že zlúčenina podta vynálezu je novej, doteraz neznámej štruk- túry a svojou antimykobakteriálnou účinnosťou, najma proti atypickým tuberkulóznym mykobaktériám je porovnatelná so známými antituberkulotikami Izoniazid a Etionamid. Zlúčeninu podta vynálezu možno používat ako účinnú zložku antimykobakteriálnych prípravkov, alebo ako medziprodukt pre ďalšie syntézy.Antimycobacterial efficacy against tuberculous mycobacteria was observed in liquid Sula under the dilution test. Dimethylsulfoxide was used as solvent. The final concentration of substances in the pod was 0.5, 1, 5, 10, 25, 50 and 100 µg. cm'3. Significant is the fact that the compound of the invention is a new, hitherto unknown structure and its antimycobacterial activity, especially against atypical tuberculous mycobacteria, is comparable to the known antituberculotics Isoniazid and Etionamide. The compound of the invention may be used as an active ingredient of antimycobacterial preparations or as an intermediate for further syntheses.

Claims (2)

PREDMETSUBJECT 1. 6-Formamido-2-benzotiazolíntión vzorca1. 6-Formamido-2-benzothiazolinothione of the formula VYNÁLEZUINVENTION 2. Sposob přípravy zlúčeniny podlá bodu 1 vyznačený tým, že sa nechá reagovat 6-amíno-2-benzotlazolíntión s 85 %-nou kyselinou mravčou v molárnom pomere 1 : 4 až 1 : 12 pri teplote 70 až 101 °C po dobu 1 až 30 minút.2. A process for the preparation of a compound as claimed in claim 1, which comprises reacting 6-amino-2-benzotlazolithione with 85% formic acid in a molar ratio of 1: 4 to 1: 12 at 70 to 101 ° C for 1 to 4 ° C. 30 minutes.
CS87927A 1987-02-12 1987-02-12 B-Formainido2 benzotiaw) líntión CS257399B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CS87927A CS257399B1 (en) 1987-02-12 1987-02-12 B-Formainido2 benzotiaw) líntión

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CS87927A CS257399B1 (en) 1987-02-12 1987-02-12 B-Formainido2 benzotiaw) líntión

Publications (2)

Publication Number Publication Date
CS92787A1 CS92787A1 (en) 1987-09-17
CS257399B1 true CS257399B1 (en) 1988-04-15

Family

ID=5342374

Family Applications (1)

Application Number Title Priority Date Filing Date
CS87927A CS257399B1 (en) 1987-02-12 1987-02-12 B-Formainido2 benzotiaw) líntión

Country Status (1)

Country Link
CS (1) CS257399B1 (en)

Also Published As

Publication number Publication date
CS92787A1 (en) 1987-09-17

Similar Documents

Publication Publication Date Title
Phillips et al. Rearrangements between primary ethanolamides of carboxylic acids and the corresponding aminoethylesters
NO139532B (en) PROCEDURE FOR AA REDUCING FRICTION LOSS IN WATER LIQUIDS THAT FLOW THROUGH A WIRE
Popp et al. Synthesis of potential anticancer agents. V. Schiff bases and related Compounds1-2
Hintermann et al. Electron transfer reactions involving trans-[PtH2 (PCy3) 2] and fluorinated benzonitriles
CS257399B1 (en) B-Formainido2 benzotiaw) líntión
DE922827C (en) Process for the preparation of quaternary ammonium salts containing 2 tetrahydroisoquinoline radicals
DE1445580A1 (en) New aminopyrazoles
US3450707A (en) Certain 2-anilino-pyridine derivatives
Keneford et al. 170. Synthetic antimalarials. Part XX. Cinnolines. Part XIII. Synthesis and antimalarial action of 4-aminoalkylaminocinnolines
DE278884C (en)
DE156901C (en)
DE730518C (en) Process for the production of amber diamide or imide
DE859304C (en) Process for the preparation of N-alkylamic acids of aliphatic dicarboxylic acids
DE635494C (en) Process for the preparation of salts of high molecular weight imido ethers, imidothio ethers and amidines
DE653010C (en) Process for the separation of leucine and ammonium chloride
US1809352A (en) Method of obtaining phenyl-azo-alpha-alpha-diamino-pyridine hydrochlorides
IL28585A (en) 3,4-dihalocinnamamides and their use as fungicides
DE937058C (en) Process for the preparation of low molecular weight trialkylamine oxides and their hydrates
US2751410A (en) 3-phenylsalicylamide
AT63822B (en) Process for the preparation of hexamethylenetetramine salts of palmitic and stearic acid.
DE928527C (en) Process for the preparation of piperidyl ketones
DE579227C (en) Process for the preparation of 6-methoxy-7-benzyloxy-1-methylisoquinoline
DE550122C (en) Process for the production of pellets of 1-benzyl-3-methylisoquinoline
DE77420C (en) Process for the preparation of p-phenetolecarbamide and p-anisolecarbamide
DE938402C (en) Process and electrolyte for the electrolytic treatment of metals and alloys